SanofiSNYNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+14.0%
5Y CAGR+19.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+14.0%/yr
vs -1.4%/yr prior
5Y CAGR
+19.9%/yr
Recent deceleration
Acceleration
+15.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $27.45B | +15.2% |
| 2024 | $23.83B | +8.2% |
| 2023 | $22.03B | +19.0% |
| 2022 | $18.52B | -1.5% |
| 2021 | $18.79B | +69.4% |
| 2020 | $11.10B | -50.9% |
| 2019 | $22.60B | +15.5% |
| 2018 | $19.57B | +4.1% |
| 2017 | $18.80B | +7.7% |
| 2016 | $17.46B | - |